The Association of the British Pharmaceutical Industry has warned that the world's biggest drug companies could abandon the UK unless the NHS receives substantially more funding.
The association represents firms including GlaxoSmithKline and AstraZeneca, as well as the UK operations of international giants like Pfizer and Novartis. It says health spending should rise from the current 9.9% of GDP to the G7 average of 11.3%. That would amount to an extra £20.8bn.
Lisa Anson, the UK boss of AstraZeneca, and new President of the ABPI tells Ian King Live why the body is making the call in its election manifesto.
